Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study

Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study

Atsushi Nishikawa,1 Fumito Yoshiki,2 Masanori Taketsuna,2 Kenta Kajimoto,2 Hiroyuki Enomoto2 1Global Patient Safety Japan, Quality and Patient Safety, Eli Lilly Japan K.K., 2Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan Abstract: Teriparatide (recombinant 1–34 N-ter...

Full description

Bibliographic Details
Main Authors:	Nishikawa A, Yoshiki F, Taketsuna M, Kajimoto K, Enomoto H
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-11-01
Series:	Clinical Interventions in Aging
Subjects:	Bone Mineral Density Chronic Kidney Disease Fragility Fracture Parathyroid Hormone Teriparatide Safety.
Online Access:	https://www.dovepress.com/safety-and-effectiveness-of-daily-teriparatide-for-osteoporosis-in-pat-peer-reviewed-article-CIA

Similar Items

Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01)

Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report
by: Nishikawa A, et al.
Published: (2016-07-01)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016-11-01)

Teriparatide and stress fracture healing in young adults (RETURN – Research on Efficacy of Teriparatide Use in the Return of recruits to Normal duty): study protocol for a randomised controlled trial
by: Alexander T. Carswell, et al.
Published: (2021-08-01)

Treatment of osteoporosis with teriparatide: The Slovenian experience
by: Kocjan Tomaz, et al.
Published: (2021-10-01)

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
by: Vishal Gupta
Published: (2013-01-01)

The effectiveness and safety of parathyroid hormone in fracture healing: A meta-analysis
by: Hao Hong, et al.
Published: (2019-04-01)

Teriparatide: A Novel Means to Ultimately Achieve True Regeneration!!!
by: Harpreet Singh Grover, et al.
Published: (2013-08-01)

Effects of teriparatide on clinical and radiologic long-term outcomes after fixation of pertrochanteric hip fractures
by: Mehdi Hosseini Khameneh, et al.
Published: (2023-01-01)

Impressive results of teriparatide treatment of postgastrectomy osteoporosis
by: Tatjana Bačun, et al.
Published: (2011-08-01)

2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)
by: Serge Ferrari, et al.
Published: (2020-09-01)

Dilemmas in the diagnosis and management of osteoporosis in a patient with alkaptonuria: Successful treatment with teriparatide
by: Ismail C. Ebrahim, et al.
Published: (2022-12-01)

The role of teriparatide in sequential and combination therapy of osteoporosis
by: Christian Meier, et al.
Published: (2014-06-01)

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
by: Barbara Hauser, et al.
Published: (2021-04-01)

Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
by: Georgios Kontogeorgos, et al.
Published: (2022-11-01)

Teriparatide - Indications beyond osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2012-01-01)

EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT
by: G. A. Batrak, et al.
Published: (2018-11-01)

Evaluation of bone densitometry by dual-energy x-ray absorptiometry as a fracture prediction tool in women with chronic kidney disease
by: Valeria E. Gómez-Islas, et al.
Published: (2020-12-01)

Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial
by: Toshihiro Nanki, et al.
Published: (2022-12-01)

Use of Parathyroid Hormone and Rehabilitation Reduces Subsequent Vertebral Body Fractures after Balloon Kyphoplasty
by: Masaki Ueno, et al.
Published: (2022-06-01)

Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives
by: Chenggui Zhang, et al.
Published: (2021-01-01)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
by: Virgínia Fernandes Moça Trevisani, et al.

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
by: Xie Z, et al.
Published: (2019-05-01)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
by: Lu C, et al.
Published: (2017-10-01)

Analysis of radiologic and clinical outcome in acute osteoporotic vertebral compression fracture: Single-agent teriparatide vs. teriparatide with subsequent vertebroplasty
by: Yongjun Jin
Published: (2023-04-01)

Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study
by: Akira Iwata, et al.
Published: (2017-04-01)

Enhancement of the effects of intermittent parathyroid hormone (1-34) by bone morphogenetic protein in a rat femoral open fracture model
by: Shozo Kanezaki, et al.
Published: (2019-11-01)

Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kümmell's Disease Patients with Severe Osteoporosis
by: Peng‐guo Gou, et al.
Published: (2021-04-01)

Effect of Teriparatide in Postmenopausal Women with Osteoporosis
by: Masoud Shayestehazar, et al.
Published: (2018-12-01)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
by: Harvinder Chhabra, et al.
Published: (2015-01-01)

Use of teriparatide in treatment of severe osteoporosis in geriatric practice: a clinical case review
by: Ekaterina N. Dudinskaya, et al.
Published: (2019-12-01)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
by: Claudia Gagnon, et al.
Published: (2008-12-01)

Teriparatide as an Effective Nonsurgical Treatment for a Patient with Basicervical Peritrochanteric Fracture Nonunion—A Case Report
by: Cheng-Han Ho, et al.
Published: (2022-07-01)

Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model
by: Yuta Tsubouchi, et al.
Published: (2018-10-01)

Triweekly administration of parathyroid hormone (1–34) accelerates bone healing in a rat refractory fracture model
by: Yohei Kumabe, et al.
Published: (2017-12-01)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
by: Toshitsugu Sugimoto, et al.
Published: (2021-03-01)

USE OF TERIPARATIDE IN SURGICAL PLANNING FOR PATIENTS WITH OSTEOPOROSIS
by: RICARDO CEPEDA JORDAN, et al.
Published: (2023-10-01)

More Evidence for Teriparatide after Fixation of Atypical Femoral Fractures: Report of Four Cases
by: Lee WC, et al.
Published: (2021-03-01)

Effect of daily teriparatide for delayed union of fracture neck of the femur
by: Jitendra Kumar Mishra, et al.
Published: (2019-01-01)

Comparison of the Efficacy of Romosozumab and Teriparatide for the Management of Osteoporotic Vertebral Compression Fractures
by: Danbi Park, et al.
Published: (2023-12-01)